Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BUD compared with GSK: revenue, margins and what each company keeps, and the suppliers and customers both name
BUD
Anheuser-Busch InBev SA
Change
Mkt cap
Revenue
Revenue
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BUD
Anheuser-Busch InBev SA
vs
GSK
GSK plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BUD, solid
GSK, dashed
BUD
Anheuser-Busch InBev SA
Change
83.97
· pre 81.77
· delayed
Mkt cap
$150.9B
GSK
GSK plc
Change
49.13
· pre 49.20
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$106.0B
vs
Compare
Pre-market
Nov 3 '26
delayed
BUD
Anheuser-Busch InBev SA
vs
GSK
GSK plc
83.97
pre 81.77
delayed
Price
49.13
pre 49.20
delayed
$150.9B
Mkt cap
$106.0B
Change
Change
BUD
83.97
vs
GSK
49.13
Pre-market
Nov 3 '26
delayed